"Our new, state-of-the-art facility in Worcester offers the convenience of primary care and specialty care under one roof. Everything has been designed to make your healthcare experience as efficient and satisfying as possible! Departments: -Behavorial Health -Dermatology -Endocrinology -IN Style Optical -Internal Medicine -Laboratory -Optometry -Podiatry -Radiology -Pediatrics -Rheumatology"

During the past decade, Reliant Medical Group conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 15 clinical trials were completed, i.e. on average, 115.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 10 clinical trials were completed. i.e. 333.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Reliant Medical Group" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "University of Massachusetts, Worcester" with 4 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored, "Brigham and Women's Hospital" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Reliant Medical Group" #1 collaborator was "Reliant Medical Group" with 4 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "American College of Surgeons" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Reliant Medical Group" are "Breast Cancer" (3 trials), "Arthritis, Rheumatoid" (2 trials), "Neoplasm Metastasis" (2 trials), "Pulmonary Disease, Chronic Obstructive" (2 trials) and "Abiraterone Acetate" (1 trials). Many other conditions were trialed in "Reliant Medical Group" in a lesser frequency.

Most popular intervention types in "Reliant Medical Group" are "Drug" (17 trials), "Other" (6 trials), "Biological" (3 trials), "Behavioral" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (4 trials), "Placebo" (4 trials), "Laboratory Biomarker Analysis" (3 trials), "Fluorouracil" (2 trials) and "Fulvestrant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Reliant Medical Group" are 20 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Reliant Medical Group". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Reliant Medical Group, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Reliant Medical Group, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 3 trials that are defined as “Not Applicable".